“…Although the dosage in the latter experiment was intentionally rather high, it was ap preciably less than rats would receive by imbibing water, con taining 1% cysteine, in volumes comparable to that consumed by untreated animals. The apparent increased severity of the disease resulting from cysteine treatment might possibly be due to the fact that cysteine is reported to be a bradykinin potentiator [3,12], and the latter is regarded as one of the mediators of in flammation [14], The fact that PPLO-induced rat polyarthritis responds to oral treatment with cysteine [6,7], while the adjuvant disease does not, may also reflect the fundamental differences in the etiology and nature of these two diseases in rats.…”